a
Bacterin, a manufacturer of bone graft material and antimicrobial coatings for medical applications, has posted revenues of $6 million for the first quarter 2011, an increase of 119 percent compared to the same quarter last year, according to a company news release.
The company's continued growth in revenue can be attributed to product penetration and continued expansion of a direct sales force. Bacterin expects to see continued revenue growth acceleration with its expanded sales force and two recently launched biologics scaffolds: Osteosponge SC and hMatrix.
Read the company news release about Bacterin's first quarter financial results.
Related Articles on Device Company Financial Results:
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
TranS1 Reports $5.1M in Q1 Revenues, 24% Decrease
DJO Global Reports $249.7M in Q1 Net Sales
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.